phenylalanine has been researched along with c-peptide in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (20.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 11 (55.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantor, P; Creutzfeldt, W; Ebert, R; Hoffmann, G; Nauck, M; Schmidt, WE; Strietzel, J | 1 |
Cantor, P; Creutzfeldt, W; Ebert, R; Hoffmann, G; Nauck, M; Reimers, J; Strietzel, J | 1 |
Kommerell, B; Limberg, B | 1 |
Futagawa, S; Iwasaki, Y; Ohkubo, A; Sanjo, T; Sato, H; Sugiura, M; Tsuji, S | 1 |
Brillon, DJ; Campbell, RG; Matthews, DE; Zheng, B | 1 |
Bier, D; Bucci, A; Dailey, G; Gerich, J; Jansson, PA; Jenssen, T; Nurjhan, N; Perriello, G; Stumvoll, M; Welle, S | 1 |
Baron, AD; Brechtel, G; Denne, SC; Golichowski, AM; Karn, CA; Zimmer, DM | 1 |
Barazzoni, R; Tessari, P; Tiengo, A; Zanetti, M | 1 |
Clark, PM; Nattrass, M; Smith, JM; Whitelaw, DC | 1 |
Dunning, BE; Foley, JE; Gatlin, MR; Haas, SJ; Hollander, PA; Schwartz, SL; Zheng, H | 1 |
Bianchi, E; Cristallo, M; Di Carlo, V; Dodesini, R; Luzi, L; Pastore, MR; Piceni Sereni, L; Pozza, G; Secchi, A; Spessot, M; Terruzzi, I | 1 |
Anderson, DM; Luzio, SD; Owens, DR | 1 |
Bell, PM; Flatt, PR; Lindsay, JR; McKillop, AM; Mooney, MH; O'Harte, FP | 1 |
Christiansen, JS; Dall, R; Jensen, MD; Jørgensen, JO; Kanaley, JA; Møller, N; Nielsen, SC | 1 |
Carroll, MF; Castro, M; Gutierrez, A; Schade, DS; Tsewang, D | 1 |
Anderson, DM; Barnett, AH; Morgan, R; Owens, DR; Shelley, S | 1 |
Mamori, S; Mori, Y; Tajima, N | 1 |
Okamoto, Y; Sugita, Y | 1 |
Groop, LC; Honkanen, EH; Isomaa, B; Sarelin, L; Tuomi, T | 1 |
Aussel, C; Carter, RE; Cynober, L; Ford, GC; Jourdan, M; Marc, J; Nair, KS; Schimke, J | 1 |
9 trial(s) available for phenylalanine and c-peptide
Article | Year |
---|---|
Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in Type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Nateglinide; Phenylalanine; Placebos; Proinsulin | 2000 |
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.
Topics: Aged; Area Under Curve; Blood Glucose; C-Peptide; Cyclohexanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Fasting; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Nateglinide; Phenylalanine; Placebos; Postprandial Period; Proinsulin; Single-Blind Method; Time Factors | 2001 |
Effects of timing of administration and meal composition on the pharmacokinetic and pharmacodynamic characteristics of the short-acting oral hypoglycemic agent nateglinide in healthy subjects.
Topics: Area Under Curve; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Double-Blind Method; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Time Factors | 2001 |
Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glycosylation; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Nateglinide; Phenylalanine; Single-Blind Method | 2003 |
Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; C-Peptide; Calorimetry, Indirect; Energy Metabolism; Exercise; Fatty Acids, Nonesterified; Human Growth Hormone; Humans; Insulin; Male; Middle Aged; Muscle Proteins; Palmitates; Phenylalanine; Tyrosine | 2004 |
Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2003 |
A placebo-controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2004 |
Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise Test; Female; Glucagon; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2006 |
Citrulline stimulates muscle protein synthesis in the post-absorptive state in healthy people fed a low-protein diet - A pilot study.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Citrulline; Cross-Over Studies; Diet, Protein-Restricted; Dietary Proteins; Female; Humans; Insulin; Insulin-Like Growth Factor I; Male; Mitochondrial Proteins; Muscle Proteins; Ornithine; Phenylalanine; Pilot Projects; Protein Biosynthesis; Tyrosine; Young Adult | 2015 |
11 other study(ies) available for phenylalanine and c-peptide
Article | Year |
---|---|
Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Topics: Adult; Blood Glucose; C-Peptide; Female; Gastric Inhibitory Polypeptide; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Metabolic Clearance Rate; Phenylalanine; Reference Values; Sincalide | 1989 |
Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man.
Topics: Adult; Bilirubin; Blood Glucose; C-Peptide; Cholecystokinin; Duodenum; Female; Glucose; Humans; Insulin; Insulin Secretion; Kinetics; Male; Phenylalanine; Reference Values; Sincalide; Trypsin | 1988 |
Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.
Topics: Amino Acids; Amino Acids, Branched-Chain; C-Peptide; Glucagon; Humans; Insulin; Liver Cirrhosis, Alcoholic; Male; Phenylalanine; Somatostatin; Tyrosine | 1984 |
Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
Topics: Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; C-Peptide; Female; Glucose Tolerance Test; Humans; Hypertension, Portal; Insulin; Liver Cirrhosis; Male; Middle Aged; Phenylalanine; Portal System; Tyrosine | 1980 |
Effect of cortisol on energy expenditure and amino acid metabolism in humans.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glutamine; Growth Hormone; Humans; Hydrocortisone; Insulin; Keto Acids; Kinetics; Leucine; Male; Phenylalanine | 1995 |
Glutamine and alanine metabolism in NIDDM.
Topics: Alanine; Blood Glucose; C-Peptide; Carbon Radioisotopes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Glucose; Glutamine; Humans; Insulin; Male; Middle Aged; Phenylalanine; Radioisotope Dilution Technique; Reference Values; Tritium | 1996 |
Glucose and amino acid turnover in untreated gestational diabetes.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Calorimetry; Carbon Dioxide; Carbon Isotopes; Diabetes, Gestational; Female; Glucose; Humans; Infusions, Intravenous; Insulin; Leucine; Oxygen Consumption; Phenylalanine; Pregnancy; Reference Values; Regression Analysis | 1996 |
Protein metabolism in glucagonoma.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Deuterium; Female; Glucagon; Glucagonoma; Humans; Infusions, Intravenous; Insulin; Leucine; Male; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins; Reference Values; Tyrosine | 1999 |
Postabsorptive muscle protein metabolism in type 1 diabetic patients after pancreas transplantation.
Topics: Adult; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Energy Intake; Forearm; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Insulin; Leucine; Middle Aged; Muscle Proteins; Muscle, Skeletal; Pancreas Transplantation; Phenylalanine; Prednisone; Protein Biosynthesis; Proteins; Reference Values; Regional Blood Flow | 2000 |
Weight loss-associated changes in acute effects of nateglinide on insulin secretion after glucose loading: results of glucose loading on 2 consecutive days.
Topics: Adipose Tissue; Administration, Oral; Blood Glucose; C-Peptide; Cyclohexanes; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male; Middle Aged; Muscle, Skeletal; Nateglinide; Obesity; Phenylalanine; Weight Loss | 2005 |
Molecular mechanism for stabilizing a short helical peptide studied by generalized-ensemble simulations with explicit solvent.
Topics: Algorithms; Arginine; Biophysics; C-Peptide; Computer Simulation; Crystallography, X-Ray; Glutamic Acid; Histidine; Models, Molecular; Models, Statistical; Peptides; Phenylalanine; Principal Component Analysis; Protein Conformation; Protein Folding; Protein Structure, Tertiary; Temperature; Thermodynamics; Time Factors; Water; X-Rays | 2005 |